Tissue banking in head and neck cancer.
Progress in the molecular oncology in head and neck cancer (HNSCC) depends on high quality appropriate tissue samples for research. The expanding availability of new molecular platforms makes ever increasing demands on any available biospecimens. HNSCC offers several key advantages over other tumour sites to the cancer researcher such that, through effective tissue collection, clinicians will be of great help the basic scientist. Informed consent and ethical approval are pre-requisites for tissue banking and it is vital to develop protocols for collection and storage such that the best possible quality of tissue is utilised in future research.
Hall
Gillian L
GL
Molecular Genetics and Oncology Group, School of Dental Sciences, University of Liverpool, Liverpool L69 3GN, UK.
Kademani
Deepak
D
Risk
Janet M
JM
Shaw
Richard J
RJ
D035843:Biomedical Research; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D028744:Ethics Committees, Research; D033161:Government Regulation; D006258:Head and Neck Neoplasms / Q000473:pathology*; D006801:Humans; D007258:Informed Consent; D014015:Tissue Banks / Q000941:ethics* / Q000331:legislation & jurisprudence